Sensei Biotherapeutics, Inc. SNSE
Sector:
HealthcareIndustry:
BiotechnologyDescription:
Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune response; and Tumor Microenvironment Activated Biologics, a platform designed to unleash the anti-tumor potential of T-cells, as well as human monoclonal antibodies that are selectively active in the tumor microenvironment and target immune checkpoints or other critical immune pathways. The company also develops SNS-101, a monoclonal antibody for the treatment of cancer; and SNS-401-NG, an ImmunoPhage vaccine targeting multiple tumor antigens. It has a collaboration with The University of Washington to research and develop Merkel cell carcinoma vaccine. The company was formerly known as Panacea Pharmaceuticals, Inc. Sensei Biotherapeutics, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.Recent Quarter:
2024-11-14Upcoming Quarter:
2025-02-26Annual Reports
Date2024-02-29
Revenue 0
Net Income -34,101,000
EPS -1.22
Basic Shares 27,952,000
Diluted Shares 27,952,857
Report Link
Date2023-05-01
Revenue 0
Net Income -48,807,000
EPS -1.59
Basic Shares 30,703,295
Diluted Shares 30,703,295
Report Link
Date2022-03-15
Revenue 0
Net Income -37,464,000
EPS -1.35
Basic Shares 27,710,686
Diluted Shares 27,710,686
Report Link
Date2021-03-30
Revenue 0
Net Income -20,629,000
EPS -0.67
Basic Shares 30,588,495
Diluted Shares 30,588,495
Report Link
Date2019-12-31
Revenue 0
Net Income -18,995,000
EPS -0.65
Basic Shares 29,325,950
Diluted Shares 29,325,950
Report Link
Date2018-12-31
Revenue 0
Net Income -13,039,000
EPS -19.03
Basic Shares 685,164
Diluted Shares 685,164
Report Link
Annual Ratios
Date2023-12-31
PE -0.57
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.94
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -4.29
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -28.02
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -29.18
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2018-12-31
PE -0.99
Dividend Yield 0.00
Payout Ratio: 0.000%
Quarterly Reports
Date2024-11-14
Revenue 0
Net Income -7,253,000
EPS -0.29
Basic Shares 25,147,999
Diluted Shares 25,147,999
Report Link
Date2024-08-06
Revenue 0
Net Income -7,142,000
EPS -0.28
Basic Shares 25,104,439
Diluted Shares 25,104,439
Report Link
Date2024-05-09
Revenue 0
Net Income -7,992,000
EPS -0.32
Basic Shares 25,049,111
Diluted Shares 25,049,111
Report Link
Date2024-02-29
Revenue 2,846,000
Net Income -7,414,000
EPS -0.3
Basic Shares 25,030,188
Diluted Shares 25,030,188
Report Link
Date2023-11-07
Revenue 0
Net Income -7,124,000
EPS -0.28
Basic Shares 25,514,115
Diluted Shares 25,514,115
Report Link
Date2023-08-03
Revenue 0
Net Income -9,386,000
EPS -0.31
Basic Shares 30,507,018
Diluted Shares 30,507,018
Report Link
Date2023-05-09
Revenue 0
Net Income -8,946,000
EPS -0.29
Basic Shares 30,866,087
Diluted Shares 30,866,087
Report Link
Date2023-05-01
Revenue 0
Net Income -12,441,000
EPS -0.4
Basic Shares 30,742,356
Diluted Shares 30,742,356
Report Link
Date2022-11-08
Revenue 0
Net Income -12,891,000
EPS -0.42
Basic Shares 30,720,291
Diluted Shares 30,720,291
Report Link
Date2022-08-09
Revenue 0
Net Income -10,358,000
EPS -0.34
Basic Shares 30,701,758
Diluted Shares 30,701,758
Report Link
Date2022-05-10
Revenue 0
Net Income -12,323,000
EPS -0.4
Basic Shares 30,647,679
Diluted Shares 30,647,679
Report Link
Date2022-03-15
Revenue 0
Net Income -9,366,000
EPS -0.31
Basic Shares 30,588,495
Diluted Shares 30,588,495
Report Link
Date2021-11-10
Revenue 0
Net Income -9,685,000
EPS -0.32
Basic Shares 30,588,495
Diluted Shares 30,588,495
Report Link
Date2021-08-11
Revenue 0
Net Income -9,771,000
EPS -0.32
Basic Shares 30,588,495
Diluted Shares 30,588,495
Report Link
Date2021-05-13
Revenue 0
Net Income -7,972,000
EPS -0.42
Basic Shares 18,904,853
Diluted Shares 18,904,853
Report Link
Date2021-03-30
Revenue 0
Net Income -5,131,000
EPS -0.27
Basic Shares 18,904,853
Diluted Shares 18,904,853
Report Link
Date2020-09-30
Revenue 0
Net Income -5,367,000
EPS -0.44
Basic Shares 12,316,554
Diluted Shares 12,316,554
Report Link
Date2020-06-30
Revenue 0
Net Income -4,910,000
EPS -0.4
Basic Shares 12,316,554
Diluted Shares 12,316,554
Report Link
Date2020-03-31
Revenue 0
Net Income -4,692,000
EPS -0.38
Basic Shares 12,316,554
Diluted Shares 12,316,554
Report Link
Date2019-12-31
Revenue 0
Net Income -6,705,000
EPS -0.54
Basic Shares 12,316,554
Diluted Shares 12,316,554
Report Link
Quarterly Ratios
Date2024-09-30
PE -0.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-06-30
PE -0.52
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2024-03-31
PE -0.82
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-12-31
PE -0.58
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-09-30
PE -0.72
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-06-30
PE -0.93
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2023-03-31
PE -1.29
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-12-31
PE -0.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-09-30
PE -0.92
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-06-30
PE -1.68
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2022-03-31
PE -1.44
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-12-31
PE -4.74
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-09-30
PE -8.31
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-06-30
PE -7.64
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2021-03-31
PE -8.61
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-12-31
PE -17.41
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-09-30
PE -10.84
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-06-30
PE -11.85
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2020-03-31
PE -12.40
Dividend Yield 0.00
Payout Ratio: 0.000%
Date2019-12-31
PE -8.68
Dividend Yield 0.00
Payout Ratio: 0.000%
RSI:
31.50Price:
$0.44Market Cap:
11,066,616EPS TTM:
-1.19PE Ratio:
-0.37PEPSG:
1.0357Fwd PE:
-0.38Volume:
454,9222 Year Price Change
0.278Index 2 Year Price Change
1.5135 Year Price Change
No Price 5 Years AgoIndex 5 Year Price Change
1.906PESPG: Growth Rate of EPS projected to next quarter and 6 months trailing. Lower is better to help calculate nexts quarters PE Ratio today. Diluted shares effects the EPS reported and makes calculation show as extremely poor expected growth.
Revenue
Net Income
EPS
Shares
News
Press Releases
Notable Earnings
Please select an option: